Quantification of Lateralized Overgrowth and Genotype‐Driven Tissue Composition
Clinical Genetics · 2025
DOI: 10.1111/cge.14713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Andrea Gazzin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pediatrics Genetics Unit, Regina Margherita Children's Hospital, Turin, Italy. Hauptthemen laut MEDLINE: Body Composition, Class I Phosphatidylinositol 3-Kinases, Growth Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lateralized overgrowth (LO) is characterized by excessive growth of one side of the body compared to the other. LO can present as isolated (ILO) or within syndromes, like Beckwith‐Wiedemann Spectrum (BWSp) and PIK3CA ‐related overgrowth spectrum (PROS). Currently, the diagnosis of LO relies on clinical evaluation and lacks a standardized method. In this study, we evaluated total body dual‐energy X‐ray absorptiometry (TB‐DXA) as a potential tool for standardizing LO assessment. Patients with LO underwent both clinical evaluation and TB‐DXA. TB‐DXA data, including total mass, mass of the three main tissue components (adipose, muscle, and bone), total mass discrepancy ratio, relative tissue composition, and discrepancy of relative tissue composition were calculated and compared with clinical findings. Differences between affected regions and the contralateral side were assessed. A total of 46 patients (61% PROS, 24% BWSp, 15% ILO) were included in this study. TB‐DXA detected overgrowth regions aligned with clinical evaluation in 91% of cases and was able to identify localized overgrowth even when clinically overlooked. Additionally, TB‐DXA revealed differences in tissue composition between affected and unaffected regions for symmetrical body areas, with these differences varying by diagnostic subgroup. Different patterns of tissue composition overgrowth were observed among different conditions, with PROS predominantly showing adipose tissue overgrowth, while BWSp/ILO mainly osteo‐muscular overgrowth. TB‐DXA is an accurate, safe, and reproducible tool in the clinical setting providing an objective method for identifying and quantifying LO. It offers valuable guidance for clinicians in the diagnosis and management of LO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pediatrics Genetics Unit, Regina Margherita Children's Hospital, Turin, Italy.
- Department of Public Health and Pediatric Sciences, University of Torino, Turin, Italy.
- Postgraduate School of Pediatrics, Department of Public Health and Pediatrics, University of Torino, Turin, Italy.
- Endocrinologia, Diabetologia e Metabolismo U, Città della Salute e della Scienza, Turin, Italy.
- Department of Biomedical Sciences and Human Oncology, University "Aldo Moro", Bari, Italy.
ORCID-Profile: Giuseppe Reynolds, Simona Cardaropoli, Nicoletta Resta, Alessandro Mussa
Zitieren
APA
Gazzin, A., Reynolds, G., Allegro, D., Rossi, D., Sciandra, F., Afkhami, H. A., Cardaropoli, S., Piglionica, M., Resta, N., Di Stefano, M., & Mussa, A. (2025). Quantification of Lateralized Overgrowth and Genotype‐Driven Tissue Composition. Clinical Genetics. https://doi.org/10.1111/cge.14713
Vancouver
Gazzin A, Reynolds G, Allegro D, Rossi D, Sciandra F, Afkhami HA, et al. Quantification of Lateralized Overgrowth and Genotype‐Driven Tissue Composition. Clinical Genetics. 2025. doi:10.1111/cge.14713
BibTeX
@article{Gazzin2025,
author = {Gazzin, Andrea and Reynolds, Giuseppe and Allegro, Damiano and Rossi, Davide and Sciandra, Francesca and Afkhami, Hirad Akberi and Cardaropoli, Simona and Piglionica, Marilidia and Resta, Nicoletta and Di Stefano, Marco and Mussa, Alessandro},
title = {Quantification of Lateralized Overgrowth and Genotype‐Driven Tissue Composition},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14713}
}
EUVIMED